Dosage and administration
adults and children 12 years of age and over: take 1 tablet not more often than every 3 to 4 hours
adults and children 12 years of age and over: take 1 tablet not more often than every 3 to 4 hours
each tablet contains: calcium 80 mg store between 20-25°C (68-77°F) retain carton for complete product information and warnings
Drug Facts
Caffeine 200 mg
Alertness aid
helps restore mental alertness or wakefulness when experiencing fatigue or drowsiness
For occasional use only
Do not use
When using this product limit the use of caffeine-containing medications, foods, or beverages while taking this product because too much caffeine may cause nervousness, irritability, sleeplessness, and, occasionally, rapid heartbeat. The recommended dose of this product contains about as much caffeine as a cup of coffee.
Stop use and ask a doctor if fatigue or drowsiness persists or continues to recur
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
colloidal silicon dioxide, croscarmellose sodium, D&C yellow #10 aluminum lake, dibasic calcium phosphate, FD&C yellow #6 aluminum lake, magnesium stearate, microcrystalline cellulose, pregelatinized starch
smart sense
NDC 49738-020-02
COMPARE TO THE ACTIVE INGREDIENT OF VIVARIN(R) TABLETS
MAXIMUM STRENGTH
stay awake
ACTUAL SIZE
CAFFEINE - ALERTNESS AID
40 TABLETS - 200 mg EACH
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 49738-020 | 49738-020-02 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d1563327-b733-4132-e053-2a95a90a223b | d83ace81-e535-4393-a186-3bf4f413b2dc | 2021-11-21 | Warnings | d1563327-b733-4132-e053-2a95a90a223b d83ace81-e535-4393-a186-3bf4f413b2dc |
Adverse event summaries are temporarily unavailable. Other product information remains available.